Thrombosis and haemostasis
Occurrence of Platelet-Monocyte Aggregates in Patients with Metabolic Disorders and Effect of Direct Anticoagulants.
Catherine Gunaseelan, Zuzana Lomozová, Marcel Hrubša, Markéta Pacliková, Pavel Skořepa, Kateřina Matoušová, Dorota Turonová, Lenka Kujovská Krcmová, Milan Bláha, Vladimír Blaha, Přemysl Mladěnka, Alejandro Carazo
Published: 202510.1055/a-2747-8963
Abstract
Platelet-monocyte aggregates (PMA) are modern biomarkers for the early onset of cardiovascular diseases (CVD). PMA occur in the presence of activated platelets (AP), whose incidence is higher in patients with metabolic diseases. These patients freque…
Preview only. Read the full abstract at the source